Bio-Rad Laboratories Inc (BIO)vsMedtronic PLC (MDT)
BIO
Bio-Rad Laboratories Inc
$264.49
-0.19%
HEALTHCARE · Cap: $7.14B
MDT
Medtronic PLC
$86.16
-0.82%
HEALTHCARE · Cap: $110.62B
Smart Verdict
WallStSmart Research — data-driven comparison
Medtronic PLC generates 1274% more annual revenue ($35.48B vs $2.58B). BIO leads profitability with a 29.4% profit margin vs 13.0%. BIO appears more attractively valued with a PEG of 1.19. BIO earns a higher WallStSmart Score of 60/100 (C).
BIO
Buy60
out of 100
Grade: C
MDT
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-55.1%
Fair Value
$189.38
Current Price
$264.49
$75.11 premium
Margin of Safety
-254.0%
Fair Value
$24.34
Current Price
$86.16
$61.82 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Keeps 29 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Large-cap with strong market position
Reasonable price relative to book value
Strong operational efficiency at 20.0%
Generating 2.3B in free cash flow
Areas to Watch
3.9% revenue growth
Weak financial health signals
Earnings declined 83.0%
Earnings declined 11.8%
Comparative Analysis Report
WallStSmart ResearchBull Case : BIO
The strongest argument for BIO centers on P/E Ratio, Price/Book, Altman Z-Score. Profitability is solid with margins at 29.4% and operating margin at 8.9%. PEG of 1.19 suggests the stock is reasonably priced for its growth.
Bull Case : MDT
The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.
Bear Case : BIO
The primary concerns for BIO are Revenue Growth, Piotroski F-Score, EPS Growth.
Bear Case : MDT
The primary concerns for MDT are EPS Growth.
Key Dynamics to Monitor
BIO carries more volatility with a beta of 1.20 — expect wider price swings.
MDT is growing revenue faster at 8.7% — sustainability is the question.
MDT generates stronger free cash flow (2.3B), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BIO scores higher overall (60/100 vs 56/100), backed by strong 29.4% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Bio-Rad Laboratories Inc
HEALTHCARE · MEDICAL DEVICES · USA
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.
Visit Website →Medtronic PLC
HEALTHCARE · MEDICAL DEVICES · USA
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?